Artificial Intelligence for Strengthening Microbiology Research Capacity in Low-Resource African Laboratories: Opportunities, Challenges, and Governance

1. Introduction

Microbiology laboratories represent a fundamental pillar of modern health systems because they provide the scientific evidence required for infectious disease detection, outbreak response, antimicrobial resistance (AMR) surveillance, vaccine development, and public health decision-making. In an increasingly interconnected world characterized by emerging pathogens, ecological disruption, climate change, and intensified human mobility, laboratory capacity has become a strategic component of global health security (World Health Organization [WHO], 2022; Gostin et al., 2024). The COVID-19 pandemic demonstrated that countries with strong laboratory networks, genomic surveillance capacity, and digital health infrastructures were better positioned to identify emerging variants, monitor transmission patterns, and design evidence-based interventions (Alm et al., 2023; WHO, 2023). Conversely, weaknesses in laboratory systems contributed to delayed detection, limited surveillance, and unequal access to scientific knowledge, particularly in low- and middle-income countries (LMICs) (Nkengasong et al., 2022).

Artificial intelligence (AI) has emerged as a major technological force transforming microbiological research and laboratory medicine. Recent advances in machine learning, deep learning, computer vision, and large-scale biological data analysis have created new possibilities for pathogen identification, antimicrobial resistance prediction, genomic surveillance, automated microscopy, microbiome analysis, and drug discovery (Topol, 2019; Jumper et al., 2021; Rajpurkar et al., 2022). AI-driven approaches enable researchers to analyze complex biological datasets generated through genomics, metagenomics, proteomics, and high-resolution imaging, allowing the discovery of patterns that are difficult or impossible to detect using conventional analytical methods (Esteva et al., 2021; Libbrecht & Noble, 2015). In microbiology, these capabilities are particularly relevant because microbial systems generate enormous volumes of heterogeneous data requiring advanced computational approaches for interpretation.

The convergence between AI and microbiology represents more than a technological improvement in laboratory efficiency; it reflects a transformation in the nature of scientific discovery. Traditional microbiological approaches have historically relied on culture-based methods, expert interpretation, and relatively linear analytical processes. Although these methods remain essential, AI enables predictive and adaptive approaches capable of integrating genomic, epidemiological, and environmental information to anticipate microbial behavior and support rapid decision-making (Quinn et al., 2023). For example, AI-assisted genomic analysis has accelerated pathogen characterization during infectious disease outbreaks, while machine learning models have demonstrated potential in predicting antimicrobial resistance profiles from genomic sequences (Arango-Argoty et al., 2018; Moradigaravand et al., 2022).

However, the global distribution of AI capabilities remains highly unequal. While advanced laboratories in North America, Europe, and parts of Asia increasingly integrate AI into microbiological workflows, many laboratories in low-resource settings continue to face fundamental challenges, including inadequate infrastructure, limited computational resources, shortages of bioinformatics expertise, unreliable electricity, weak data systems, and insufficient research financing (WHO, 2022; African Union, 2024). These structural limitations create a paradox: regions experiencing some of the highest burdens of infectious diseases often possess the least capacity to benefit from emerging technological innovations.

Africa provides an important context for examining this challenge. The continent faces a substantial burden of infectious diseases, including malaria, tuberculosis, HIV/AIDS, Ebola virus disease, cholera, Mpox, and antimicrobial-resistant infections (WHO, 2023). Yet African scientific institutions have demonstrated significant capacity for innovation and resilience. The COVID-19 pandemic particularly revealed the growing contribution of African laboratories to global microbiology. Through investments in genomic surveillance, molecular diagnostics, and regional scientific collaboration, several African countries demonstrated that advanced microbiological research can emerge within resource-constrained environments (Tegally et al., 2021; Happi & Ihekweazu, 2021).

South Africa represents one of the strongest examples of African leadership in genomic microbiology. The KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP) played a globally recognized role in SARS-CoV-2 genomic surveillance by rapidly identifying and characterizing important viral variants during the COVID-19 pandemic (Tegally et al., 2021). This achievement illustrated the importance of combining laboratory infrastructure, computational expertise, institutional leadership, and international scientific networks. The South African experience demonstrates that AI-enabled microbiology depends not only on algorithms but also on broader scientific ecosystems capable of generating, managing, and interpreting complex biological data.

Senegal provides another important example through the Institut Pasteur de Dakar, which has historically contributed to vaccine research, infectious disease surveillance, and regional laboratory capacity development. During the COVID-19 response, Senegal expanded molecular diagnostic capacity and strengthened its role as a regional scientific hub in West Africa (Happi & Ihekweazu, 2021). Similarly, Kenya has developed significant expertise through institutions such as the Kenya Medical Research Institute (KEMRI), particularly in malaria research, pathogen surveillance, and antimicrobial resistance studies (Scott et al., 2022). Nigeria has also strengthened infectious disease preparedness through the Nigeria Centre for Disease Control and Prevention (NCDC), integrating laboratory systems with epidemiological surveillance networks to improve outbreak response (Ihekweazu & Agogo, 2020).

Uganda represents another important case because of its extensive experience managing viral hemorrhagic fever outbreaks, including Ebola. The country’s investments in laboratory preparedness, genomic surveillance, and international scientific collaboration demonstrate how repeated public health challenges can stimulate institutional learning and microbiological capacity development (Kibuuka et al., 2023). The Central African Republic has also provided evidence that simplified and innovative laboratory approaches can improve microbiological access in low-resource settings, particularly through adapted diagnostic platforms designed for environments with limited infrastructure (Pépin et al., 2025).

The Democratic Republic of the Congo (DRC) offers a particularly significant case for understanding the relationship between laboratory capacity, technological innovation, and public health resilience. The country has experienced repeated outbreaks of Ebola virus disease, cholera, measles, COVID-19, and Mpox, requiring continuous development of diagnostic and surveillance capabilities. The Institut National de Recherche Biomédicale (INRB) has become one of Africa’s most recognized biomedical institutions through its involvement in pathogen detection, outbreak response, vaccine research, and international scientific collaboration (Muyembe-Tamfum et al., 2012; Breman et al., 2021). Nevertheless, significant challenges remain, including infrastructure limitations, uneven digitalization, shortages of specialized personnel, and restricted access to advanced computational resources. These challenges raise important questions about how AI can be integrated into existing laboratory ecosystems without reproducing technological dependency.

Despite growing interest in AI applications in healthcare, existing research has insufficiently examined the relationship between AI adoption and microbiology research capacity development in low-resource environments. Much of the current literature focuses on algorithm performance, clinical accuracy, or computational innovation, while paying less attention to the institutional conditions required for sustainable implementation. AI systems require not only technological infrastructure but also reliable datasets, trained professionals, ethical governance frameworks, institutional leadership, and collaborative scientific networks (Morley et al., 2020; UNESCO, 2021). Therefore, understanding AI adoption in microbiology requires moving beyond a technology-centered perspective toward a broader analysis of scientific capacity building.

This article addresses this research gap by examining how artificial intelligence can strengthen microbiology research capacity in low-resource African laboratories. It argues that AI should not be understood simply as a technological tool but as part of a broader transformation of laboratory ecosystems involving infrastructure, human capital, governance, data systems, and international collaboration. Through comparative analysis of selected African experiences, including South Africa, Senegal, Kenya, Nigeria, Uganda, the Central African Republic, and the Democratic Republic of the Congo, this study identifies both opportunities and barriers associated with AI-enabled microbiological research.

The article makes three contributions. First, it provides an empirically grounded analysis of AI applications in African microbiology laboratories rather than a purely theoretical discussion. Second, it identifies institutional and governance conditions necessary for responsible AI integration in low-resource scientific environments. Third, it proposes an African AI Laboratory Capacity Framework designed to support policymakers, universities, research institutions, and international partners seeking to strengthen microbiological sovereignty through responsible technological innovation.

By linking artificial intelligence, microbiology, and scientific capacity building, this study contributes to broader debates on digital transformation, global health equity, and the future of research systems in Africa. It demonstrates that the transformative potential of AI will depend not only on technological availability but also on the ability of institutions to cultivate resilient, inclusive, and sustainable scientific ecosystems.

2. Literature Review

2.1. Artificial Intelligence and the Transformation of Microbiology

The integration of artificial intelligence (AI) into microbiology represents a major transformation in the way microorganisms are detected, classified, monitored, and understood. Traditional microbiological approaches have historically relied on culture-based methods, microscopy, biochemical testing, and expert interpretation. Although these approaches remain fundamental, they are often time-consuming and limited in their ability to process the increasing volume and complexity of biological data generated by modern laboratories. The emergence of machine learning (ML) and deep learning (DL) has introduced new possibilities for automated, predictive, and data-driven microbiological research (Libbrecht & Noble, 2015; Rajpurkar et al., 2022).

Machine learning algorithms are increasingly applied to identify complex patterns within genomic sequences, laboratory images, and epidemiological datasets. In microbiology, these approaches have contributed to microbial classification, pathogen identification, antimicrobial resistance prediction, and biological discovery. Deep learning models, particularly convolutional neural networks, have demonstrated significant potential in automated image recognition, enabling improved interpretation of microscopy data and supporting faster diagnostic decisions (Esteva et al., 2021).

AI-assisted diagnosis represents one of the most promising applications of these technologies. Automated systems can support bacterial colony recognition, parasite detection, microbial classification, and clinical decision-making. These innovations are particularly relevant in low-resource environments where shortages of specialized laboratory personnel may delay diagnosis and treatment. By increasing diagnostic capacity and reducing workload pressure on laboratory professionals, AI has the potential to strengthen microbiological services in settings where expertise remains unevenly distributed (Topol, 2019).

AI-assisted microscopy is also transforming laboratory workflows through automated image acquisition, interpretation, and quality assurance. Digital microscopy combined with machine learning can facilitate remote laboratory support, improve diagnostic consistency, and expand access to specialized expertise through telemicrobiology approaches (Rajpurkar et al., 2022). However, successful AI integration requires more than technological adoption. It depends on reliable data systems, appropriate infrastructure, trained professionals, ethical governance, and institutional readiness.

2.2. AI, Genomics, and Antimicrobial Resistance Surveillance

The convergence of AI and microbial genomics has created new opportunities for understanding pathogen evolution, monitoring outbreaks, and addressing antimicrobial resistance (AMR). Whole genome sequencing (WGS) has transformed microbiology by allowing researchers to analyze microorganisms at unprecedented molecular resolution. However, the large-scale datasets produced by genomic technologies require advanced computational approaches for interpretation and application (Quainoo et al., 2017).

AI-based genomic analysis enables rapid identification of mutations, reconstruction of transmission pathways, and prediction of pathogen characteristics. During the COVID-19 pandemic, genomic surveillance networks demonstrated the importance of combining sequencing technologies with computational methods to detect emerging variants and understand viral evolution (Tegally et al., 2021). Similar approaches are increasingly relevant for Ebola virus, Mpox, tuberculosis, malaria, and other pathogens affecting African populations.

Antimicrobial resistance represents another major area where AI can contribute significantly. Machine learning models can analyze bacterial genomic information to identify resistance-associated genes and predict antimicrobial susceptibility patterns, potentially improving treatment decisions and reducing inappropriate antibiotic use (Arango-Argoty et al., 2018; Moradigaravand et al., 2022).

AI also supports One Health surveillance approaches by integrating human, animal, and environmental health data. Because emerging infectious diseases often arise from complex interactions between ecosystems, animals, and human populations, AI-driven analytical systems may improve early warning mechanisms and strengthen preparedness strategies (Destoumieux-Garzón et al., 2018). Nevertheless, these applications require sustainable genomic infrastructures, trained bioinformaticians, and effective data governance systems.

2.3. Scientific Capacity Building in African Laboratories

Scientific capacity building has become a central priority for strengthening Africa’s ability to detect and respond to infectious disease threats. Historically, many African countries relied heavily on external laboratories for advanced microbiological analyses. However, recent health emergencies have accelerated efforts to develop locally owned laboratory systems, genomic networks, and research capabilities (Nkengasong et al., 2022).

Laboratory strengthening requires coordinated development of physical infrastructure, workforce capabilities, digital systems, quality management, and sustainable financing. The COVID-19 pandemic demonstrated that countries with stronger laboratory networks were better positioned to expand molecular diagnostics, genomic sequencing, and disease surveillance.

The expansion of genomic capacity has become particularly important. The Africa Centres for Disease Control and Prevention (Africa CDC) Pathogen Genomics Initiative represents a major continental effort to increase sequencing capacity, strengthen bioinformatics expertise, and promote regional collaboration in pathogen surveillance (Africa CDC, 2022). This initiative reflects a broader movement toward scientific autonomy and locally generated knowledge production.

Despite significant progress, many African laboratories continue to face structural challenges, including limited access to advanced equipment, inadequate computational infrastructure, unstable electricity, insufficient digital connectivity, and shortages of specialized personnel. These constraints directly affect AI adoption because artificial intelligence depends on high-quality data, digital readiness, and multidisciplinary expertise.

2.4. Research Gap

The existing literature on AI and microbiology has generated substantial advances in algorithm development, diagnostic accuracy, and computational performance. However, research has paid comparatively less attention to the institutional and systemic conditions necessary for sustainable AI integration.

First, limited attention has been devoted to institutional capacity, particularly the ability of laboratories to generate, manage, and interpret complex biological datasets. Second, governance issues related to responsible AI deployment, ethical data management, regulatory frameworks, and equitable access remain insufficiently explored. Third, workforce development challenges, including shortages of bioinformatics specialists, data scientists, and AI-trained microbiologists, require greater scholarly attention.

This study addresses these gaps by examining AI integration as a broader scientific capacity-building process rather than merely a technological intervention.

3. Methodology

3.1. Research Design

This study adopts a qualitative comparative research design combining systematic literature review, comparative case study analysis, and policy document analysis.

The literature review examines recent scientific contributions on AI applications in microbiology, genomic surveillance, antimicrobial resistance, and laboratory transformation. The comparative case study approach investigates selected African laboratory systems that demonstrate significant microbiological capacity, outbreak response experience, and potential for AI integration. Policy document analysis complements these approaches by examining strategic frameworks developed by international and continental organizations, including WHO and Africa CDC.

This methodological design enables the study to analyze not only technological opportunities but also the institutional, governance, and ecosystem conditions influencing AI adoption.

3.2. Data Sources

The study uses multiple categories of evidence, including peer-reviewed scientific articles published between 2019 and 2026, WHO reports on laboratory systems and antimicrobial resistance, Africa CDC publications on pathogen genomics, national laboratory reports, and institutional publications from leading African research centers.

The selection of sources prioritizes empirical studies and authoritative reports addressing AI applications, microbiological innovation, genomic surveillance, and scientific capacity development.

3.3. Case Selection

The cases were selected purposively according to four criteria: demonstrated microbiological research capacity, experience with infectious disease outbreaks, involvement in genomic surveillance activities, and relevance for future AI adoption.

Table 1. Selected African Microbiology Laboratory Systems and Their Contributions to AI-Enabled Scientific Capacity Development.

Country	Institution/System	Main contribution
South Africa	KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP)	Genomic surveillance and pathogen sequencing
Senegal	Institut Pasteur de Dakar	Regional diagnostics and vaccine research
Kenya	Kenya Medical Research Institute (KEMRI)	Research networks and infectious disease studies
Nigeria	Nigeria Centre for Disease Control and Prevention (NCDC)	Disease surveillance and laboratory coordination
Uganda	National laboratory systems	Viral outbreak preparedness
Democratic Republic of Congo	Institut National de Recherche Biomédicale (INRB)	Ebola, Mpox, and pathogen surveillance
Central African Republic	Mini-Lab model	Low-resource laboratory innovation

Table 1. Selected African Microbiology Laboratory Systems and Their Contributions to AI-Enabled Scientific Capacity Development.

Country	Institution/System	Main contribution
South Africa	KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP)	Genomic surveillance and pathogen sequencing
Senegal	Institut Pasteur de Dakar	Regional diagnostics and vaccine research
Kenya	Kenya Medical Research Institute (KEMRI)	Research networks and infectious disease studies
Nigeria	Nigeria Centre for Disease Control and Prevention (NCDC)	Disease surveillance and laboratory coordination
Uganda	National laboratory systems	Viral outbreak preparedness
Democratic Republic of Congo	Institut National de Recherche Biomédicale (INRB)	Ebola, Mpox, and pathogen surveillance
Central African Republic	Mini-Lab model	Low-resource laboratory innovation

The selected cases represent diverse African scientific contexts, ranging from highly developed genomic platforms such as KRISP to innovative low-resource laboratory models such as the Mini-Lab approach. Together, they provide comparative insights into different pathways through which AI could strengthen microbiology research capacity under varying institutional and infrastructural conditions.

3.4. Analytical Framework

The analysis applies six interconnected dimensions to evaluate AI readiness and microbiology transformation.

The first dimension concerns infrastructure readiness, including laboratory facilities, sequencing capacity, digital systems, and computational resources. The second examines digital and data capacity, focusing on data generation, storage, interoperability, and bioinformatics capability. The third dimension evaluates human capital, including microbiologists, bioinformaticians, data scientists, and training systems.

The fourth dimension considers AI application potential, particularly applications in diagnosis, genomics, antimicrobial resistance surveillance, and scientific discovery. The fifth dimension examines governance and ethics, including responsible AI principles, data protection, regulatory capacity, and equitable access. The sixth dimension analyzes scientific collaboration ecosystems, including partnerships among universities, governments, research institutes, international organizations, and regional networks.

Together, these dimensions provide a systemic framework for understanding not only whether AI technologies are available, but whether African microbiology laboratories possess the institutional conditions required for sustainable and responsible AI-enabled transformation.

4. AI Applications in African Microbiology Laboratories

4.1. AI-Enabled Diagnostics

Artificial intelligence-enabled diagnostics represent one of the most promising applications of AI in microbiology laboratories. In many African health systems, delayed diagnosis remains a persistent challenge due to limited laboratory infrastructure, shortages of trained personnel, geographical barriers, and dependence on centralized diagnostic facilities (Nkengasong et al., 2022; WHO, 2023). AI technologies offer new possibilities for improving diagnostic speed, accuracy, and accessibility through machine learning algorithms, digital microscopy, automated image recognition, and decision-support systems (Topol, 2019; Rajpurkar et al., 2022).

AI-based diagnostic platforms can analyze microscopy images, identify microbial structures, classify pathogens, and support laboratory decision-making. Deep learning models, particularly convolutional neural networks, have demonstrated significant capabilities in recognizing biological patterns from medical images and improving diagnostic performance in specific clinical contexts (Esteva et al., 2019; Rajpurkar et al., 2022). In microbiology, these approaches are increasingly applied to bacterial colony recognition, parasite identification, fungal classification, and automated interpretation of laboratory results (Mohseni & Ghorbani, 2024).

The relevance of AI-assisted diagnostics is particularly significant for African laboratories facing shortages of specialized microbiologists. Automated systems can function as decision-support mechanisms, increasing diagnostic capacity while allowing laboratory professionals to focus on complex cases requiring expert interpretation (Topol, 2019). For diseases such as malaria, tuberculosis, bloodstream infections, and neglected tropical diseases, AI-supported diagnostic platforms may contribute to earlier detection and improved treatment outcomes (WHO, 2023).

However, AI diagnostic systems also present important implementation challenges. Many African laboratories lack the digital infrastructure required for deployment, including high-quality imaging equipment, stable connectivity, electronic laboratory information systems, and computational resources (Africa CDC, 2022). Furthermore, AI models trained predominantly on datasets from high-income countries may demonstrate reduced accuracy when applied to African populations because of differences in disease epidemiology, microbial diversity, and laboratory conditions (Morley et al., 2020). Developing locally generated datasets and African-specific AI models is therefore essential for equitable adoption.

4.2. Genomic Surveillance and Pathogen Tracking

Genomic surveillance has transformed modern microbiology by enabling researchers to characterize pathogens, monitor evolutionary changes, identify transmission patterns, and support outbreak response (Quainoo et al., 2017). The integration of AI with genomic technologies further expands these capabilities by enabling rapid analysis of large-scale sequencing datasets and improving prediction of pathogen behavior (Libbrecht & Noble, 2015).

The COVID-19 pandemic demonstrated the strategic importance of combining genomic sequencing with advanced computational approaches. African scientists made significant contributions to global pathogen surveillance through sequencing initiatives that identified emerging SARS-CoV-2 variants and supported international response efforts (Tegally et al., 2021; Happi & Ihekweazu, 2021). AI-based analytical methods can strengthen these systems by automating genomic classification, detecting mutations, and identifying patterns associated with pathogen evolution (Rajpurkar et al., 2022).

Beyond COVID-19, AI-supported genomic surveillance has important applications for Ebola virus disease, Mpox, tuberculosis, malaria parasites, and antimicrobial-resistant organisms. These technologies can improve early warning systems by integrating genomic, epidemiological, and environmental information (Destoumieux-Garzón et al., 2018).

For African laboratories, however, genomic AI applications require broader investments in sequencing infrastructure, bioinformatics expertise, data governance, and regional collaboration. The Africa CDC Pathogen Genomics Initiative represents a major continental effort to strengthen these capacities by expanding sequencing networks, developing technical expertise, and promoting regional cooperation (Africa CDC, 2022).

4.3. Antimicrobial Resistance Prediction

Antimicrobial resistance (AMR) represents one of the most critical challenges facing global microbiology. The increasing emergence of resistant microorganisms threatens the effectiveness of existing antimicrobial therapies and requires innovative surveillance approaches (WHO, 2024). African countries face particular challenges because many laboratories lack comprehensive AMR monitoring systems and sufficient diagnostic capacity (Nkengasong et al., 2022).

AI offers new opportunities for AMR surveillance by enabling prediction of resistance profiles from microbial genomic data. Machine learning approaches can identify resistance-associated genes, analyze bacterial genomes, and predict antimicrobial susceptibility patterns (Arango-Argoty et al., 2018). These approaches have demonstrated potential to reduce diagnostic delays and support more precise antimicrobial treatment strategies (Moradigaravand et al., 2022).

The application of AI to AMR surveillance is especially relevant within a One Health framework, which recognizes that antimicrobial resistance emerges through interactions between humans, animals, food systems, and environmental ecosystems (Destoumieux-Garzón et al., 2018). AI systems capable of integrating clinical, genomic, agricultural, and environmental datasets could provide a more comprehensive understanding of resistance dynamics.

Nevertheless, AI-based AMR prediction depends heavily on the availability of representative genomic databases. Since many African bacterial populations remain underrepresented in global datasets, developing African genomic repositories is essential to avoid biased predictions and strengthen locally relevant AI models (Happi & Ihekweazu, 2021).

4.4. AI-Assisted Drug and Vaccine Discovery

Artificial intelligence is increasingly transforming pharmaceutical research by accelerating the discovery of antimicrobial compounds, vaccines, and therapeutic interventions. Traditional drug discovery approaches require significant financial investment and lengthy development periods, whereas AI approaches can analyze molecular structures, predict biological interactions, and identify potential therapeutic candidates more efficiently (Jumper et al., 2021; Rajpurkar et al., 2022).

The development of advanced AI systems for protein structure prediction represents a major breakthrough in biomedical research. AlphaFold demonstrated the ability of AI to predict protein structures with unprecedented accuracy, creating new possibilities for understanding microbial proteins and designing targeted interventions (Jumper et al., 2021).

For Africa, AI-assisted drug and vaccine discovery presents an opportunity to strengthen participation in global biomedical innovation. The continent possesses unique microbial diversity and faces disease burdens requiring locally relevant solutions. However, meaningful participation requires investment in computational biology, research infrastructure, intellectual property systems, and scientific training (Africa Union, 2024).

Without such investments, African countries risk remaining consumers rather than producers of AI-driven biomedical innovations.

5. Empirical Evidence: African Laboratory Experiences

5.1. South Africa: KRISP and Genomic Leadership

South Africa represents one of the strongest examples of African scientific leadership in genomic microbiology. The KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP) demonstrated the importance of integrating sequencing infrastructure, bioinformatics expertise, and international scientific collaboration during the COVID-19 pandemic (Tegally et al., 2021).

The identification and characterization of the Beta SARS-CoV-2 variant illustrated the capacity of African laboratories to contribute to global pathogen surveillance (Tegally et al., 2021). This experience provides important lessons for AI adoption because it demonstrates that advanced computational technologies depend on strong institutional foundations, trained scientists, and sustainable research ecosystems.

5.2. Senegal: Building Regional Diagnostic Capacity

Senegal has developed one of Africa’s most recognized biomedical research environments through institutions such as the Institut Pasteur de Dakar. The country has demonstrated expertise in vaccine research, infectious disease diagnostics, and regional laboratory cooperation (Happi & Ihekweazu, 2021).

During the COVID-19 pandemic, Senegal expanded molecular diagnostic capacity and developed innovative approaches adapted to local conditions. These experiences demonstrate how African scientific institutions can combine technological innovation with public health priorities (WHO, 2023).

For AI integration, Senegal provides an example of how regional scientific hubs can support knowledge exchange, workforce development, and collaborative laboratory networks.

5.3. Kenya and Nigeria: Surveillance Networks and Digital Integration

Kenya and Nigeria illustrate the importance of connecting microbiological laboratories with national surveillance systems. The Kenya Medical Research Institute (KEMRI) has developed extensive expertise in infectious disease research, epidemiology, and laboratory-based investigations (Scott et al., 2022).

Nigeria, through the Nigeria Centre for Disease Control and Prevention (NCDC), has strengthened laboratory coordination and disease surveillance mechanisms (Ihekweazu & Agogo, 2020). These experiences demonstrate that AI adoption requires effective integration between laboratory data systems, public health institutions, and decision-making structures.

5.4. Uganda: Laboratory Preparedness from Outbreak Experience

Uganda’s experience managing viral outbreaks, particularly Ebola virus disease, has contributed to the development of important laboratory preparedness capacities. Repeated outbreak responses have strengthened molecular diagnostics, surveillance networks, and international scientific collaboration (Nkengasong et al., 2022).

The Ugandan experience demonstrates that crisis-driven learning can contribute to institutional resilience. For AI adoption, it highlights the importance of preparedness, workforce development, and sustainable laboratory investment.

5.5. Democratic Republic of Congo: Scientific Resilience Under Epidemic Pressure

The Democratic Republic of Congo represents a significant example of scientific resilience under epidemic pressure. Recurrent outbreaks of Ebola, Mpox, cholera, and other infectious diseases have required continuous strengthening of diagnostic and surveillance capacities (Muyembe-Tamfum et al., 2012; Breman et al., 2021).

The Institut National de Recherche Biomédicale (INRB) has become one of Africa’s leading biomedical institutions through its contributions to pathogen detection, outbreak response, vaccine research, and international collaboration (Muyembe-Tamfum et al., 2012).

However, AI integration remains constrained by infrastructure limitations, digital inequalities, and shortages of specialized computational expertise. The DRC case therefore illustrates both the potential and the challenges of AI-enabled microbiology in complex environments.

5.6. Central African Republic: Innovation Under Resource Constraints

The Central African Republic provides an example of laboratory innovation under severe resource constraints. Low-cost and decentralized laboratory models demonstrate that microbiological capacity strengthening can occur through adaptive approaches rather than only through large-scale infrastructure investments (WHO, 2022).

These experiences are particularly relevant for AI because they emphasize the importance of designing technologies adapted to local realities. AI solutions for African laboratories must therefore prioritize affordability, sustainability, interoperability, and local ownership.

6. Challenges of AI Adoption in African Microbiology

The adoption of artificial intelligence in African microbiology laboratories offers significant opportunities for strengthening diagnosis, genomic surveillance, antimicrobial resistance monitoring, and scientific innovation. However, AI implementation is not simply a matter of introducing advanced algorithms into laboratory environments. It requires a complex ecosystem involving infrastructure, data systems, human capabilities, financing mechanisms, institutional governance, and ethical frameworks. In many African contexts, the main challenge is not the absence of technological interest but the existence of structural constraints that limit sustainable integration.

6.1. Infrastructure Limitations

Infrastructure represents one of the most fundamental barriers to AI adoption in African microbiology laboratories. Artificial intelligence systems require reliable digital infrastructure, including high-performance computing capacity, secure data storage, advanced laboratory information systems, stable electricity, and high-speed internet connectivity. However, many laboratories continue to operate under conditions where basic infrastructure remains insufficient (WHO, 2022; Africa CDC, 2022).

The challenge is particularly important because microbiology is increasingly dependent on data-intensive technologies such as whole genome sequencing, metagenomics, digital microscopy, and automated diagnostic platforms. Without adequate computational resources, laboratories may generate biological data but remain unable to process and interpret them locally. This creates a form of technological dependency where African institutions collect samples while advanced analytical processes are performed elsewhere (Happi & Ihekweazu, 2021).

The infrastructure challenge is therefore not limited to physical equipment but concerns the entire digital ecosystem required for AI-enabled scientific production.

6.2. Data Governance and Digital Inequality

AI systems depend fundamentally on access to high-quality, representative, and ethically managed datasets. In microbiology, data quality determines the reliability of AI models used for pathogen identification, genomic surveillance, and antimicrobial resistance prediction. However, African laboratories remain underrepresented in global biological databases, creating risks of algorithmic bias and reduced performance when AI systems are applied to African populations (Morley et al., 2020).

Data governance challenges include questions of ownership, sovereignty, sharing mechanisms, privacy protection, and equitable benefit distribution. Historically, biological samples and genomic information from African populations have often been analyzed outside the continent, limiting local scientific ownership and capacity development. Responsible AI adoption requires governance frameworks that ensure African institutions participate not only as data providers but also as knowledge producers.

The emergence of continental initiatives such as Africa CDC’s Pathogen Genomics Initiative demonstrates progress toward strengthening African control over genomic data and surveillance systems (Africa CDC, 2022).

6.3. Workforce and Skills Gaps

The successful implementation of AI in microbiology requires interdisciplinary expertise combining microbiology, genomics, bioinformatics, artificial intelligence, statistics, and data science. A major challenge across many African countries is the limited availability of professionals trained at the intersection of these disciplines.

Traditional microbiology training has rarely incorporated advanced computational skills, while AI specialists may lack sufficient understanding of biological systems. Bridging this gap requires new educational models that integrate life sciences, computer science, and public health (Topol, 2019).

Workforce development must therefore become a central component of AI strategies. Investments in postgraduate training, research fellowships, laboratory partnerships, and digital learning platforms will determine whether African institutions can develop sustainable AI capabilities.

6.4. Financial Sustainability

AI adoption requires long-term investment beyond initial technology acquisition. The costs associated with computational infrastructure, software development, maintenance, training, data management, and cybersecurity can represent significant barriers for laboratories operating under limited research budgets.

Many African research institutions remain dependent on short-term external funding mechanisms, which may support specific projects but do not always guarantee sustainable institutional transformation. Long-term AI integration requires national investment strategies, regional financing mechanisms, and stronger partnerships between governments, universities, industry, and international organizations (Nkengasong et al., 2022).

Financial sustainability is therefore closely connected to scientific sovereignty. Without stable investment, AI risks becoming another externally controlled technology rather than a locally embedded scientific capability.

6.5. Ethical and Responsible AI Issues

Responsible AI adoption requires attention to ethical challenges related to transparency, accountability, privacy, and fairness. In microbiology, AI systems increasingly influence decisions related to diagnosis, treatment strategies, outbreak prediction, and public health interventions.

African countries face the additional challenge of developing regulatory frameworks capable of governing AI technologies while ensuring innovation is not unnecessarily restricted. Questions concerning genomic data protection, cross-border data sharing, algorithmic bias, and equitable access to AI benefits require coordinated policy responses (UNESCO, 2021).

Responsible AI governance must therefore ensure that technological advancement is aligned with principles of human dignity, public benefit, scientific inclusion, and health equity.

Table 2 demonstrates that AI adoption challenges in African microbiology are interconnected rather than isolated. Infrastructure limitations affect data generation; data limitations affect AI performance; workforce shortages affect implementation; and governance weaknesses influence sustainability. Therefore, AI readiness must be approached as a systemic capacity-building process.

7. An African AI Laboratory Capacity Framework: Toward Sustainable Artificial Intelligence Integration in Microbiology

The analysis of African microbiology laboratories demonstrates that artificial intelligence adoption cannot be reduced to the acquisition of algorithms, software platforms, or automated diagnostic tools. AI represents a socio-technical transformation that requires the simultaneous development of infrastructure, knowledge systems, institutional capabilities, governance mechanisms, and scientific networks. Based on the comparative evidence examined in this study, this article proposes the African AI Laboratory Capacity Framework (AIALCF) as an integrated model for guiding responsible and sustainable AI adoption in microbiology laboratories.

The framework departs from technology-centered approaches that assume digital innovation automatically produces scientific transformation. Instead, it argues that AI effectiveness depends on the existence of an enabling ecosystem in which technological capabilities, human expertise, institutional structures, and ethical governance reinforce each other. In this perspective, AI becomes not merely a tool for laboratory optimization but a strategic instrument for building scientific capacity, strengthening health sovereignty, and improving Africa’s contribution to global biomedical knowledge production.

The framework is organized around six mutually reinforcing pillars.

7.1. Smart Laboratory Infrastructure

The first pillar focuses on the creation of smart laboratory environments capable of supporting AI-driven microbiological research and public health applications. Smart laboratory infrastructure includes advanced diagnostic equipment, genomic sequencing platforms, digital microscopy systems, laboratory information management systems, cloud-based computational resources, and secure communication networks.

Many African laboratories have historically operated under infrastructure constraints that limit their ability to perform advanced microbiological analyses. While significant progress has been achieved through investments in molecular diagnostics and genomic surveillance, disparities remain between countries and between urban research centers and peripheral laboratories (Africa CDC, 2022).

AI adoption requires moving beyond traditional laboratory modernization toward digitally connected ecosystems. A smart laboratory should be capable of generating high-quality biological data, transmitting information securely, integrating multiple analytical platforms, and supporting real-time decision-making.

However, the objective should not be technological imitation of high-income laboratory models. African contexts require adaptive infrastructure approaches that consider electricity reliability, maintenance capacity, financial constraints, and local epidemiological priorities. Innovative models such as decentralized laboratories, mobile diagnostic platforms, and regional computational hubs may provide more sustainable pathways.

The concept of smart laboratory infrastructure therefore emphasizes resilience, accessibility, and local ownership rather than technological complexity alone.

7.2. AI and Digital Readiness

The second pillar concerns the capacity of institutions to effectively adopt and utilize AI technologies. Digital readiness involves more than access to computers or internet connectivity. It includes data availability, computational capacity, software ecosystems, cybersecurity, institutional strategies, and organizational willingness to integrate AI into laboratory workflows.

African microbiology laboratories generate increasing amounts of biological information through sequencing, surveillance, and diagnostic activities. However, the transformation of this information into scientific intelligence requires digital systems capable of storing, processing, and interpreting complex datasets.

Digital readiness also requires institutional transformation. Laboratories must develop AI implementation strategies that identify priority applications, establish responsible use procedures, and integrate AI tools into existing scientific practices. Without institutional planning, AI risks remaining limited to pilot projects that do not achieve long-term impact.

Therefore, digital readiness represents the bridge between technological availability and meaningful scientific application.

7.3. Scientific Workforce Development

The third pillar recognizes that human capacity remains the foundation of AI-enabled microbiology. Artificial intelligence does not eliminate the need for scientific expertise; rather, it changes the type of expertise required.

Future microbiology laboratories will require professionals capable of combining biological knowledge with computational skills. Microbiologists will need familiarity with data science, machine learning concepts, and genomic analysis, while AI specialists will require deeper understanding of biological systems and public health applications.

This interdisciplinary workforce cannot be created through short-term training alone. It requires transformation of university curricula, expansion of postgraduate programs, establishment of research fellowships, and development of institutional partnerships between microbiology departments, computer science programs, and public health schools.

African scientific institutions must therefore invest in a new generation of researchers capable of producing, adapting, and governing AI technologies rather than merely consuming externally developed solutions.

Workforce development is consequently not only a technical requirement but also a foundation for scientific sovereignty.

7.4. Data Governance and Interoperability

The fourth pillar addresses one of the most critical elements of AI development: data. Artificial intelligence systems are only as effective as the quality, diversity, and governance of the datasets on which they are trained.

African microbiology faces a historical imbalance in global scientific databases. Many African pathogens, microbial populations, and epidemiological patterns remain insufficiently represented in international datasets. This creates the risk that AI models developed elsewhere may fail to accurately reflect African realities.

Data governance must therefore become a strategic priority. African institutions need mechanisms that ensure responsible data collection, ethical management, scientific ownership, and equitable participation in international research networks.

Interoperability is equally important. Laboratories across countries must be able to exchange information through compatible systems while maintaining appropriate security and ethical safeguards. Regional data platforms could strengthen collective intelligence and improve continental preparedness against emerging infectious diseases.

The future of AI-enabled microbiology depends not only on producing more data but on building trustworthy and sovereign data ecosystems.

7.5. Regional Collaboration Networks

The fifth pillar emphasizes the importance of collaboration beyond national boundaries. Infectious diseases are transnational phenomena, and no individual country can independently develop all required scientific capacities.

Regional collaboration networks can facilitate shared sequencing platforms, joint research programs, knowledge exchange, workforce training, and coordinated surveillance systems. Initiatives led by Africa CDC demonstrate the potential of continental cooperation in strengthening pathogen genomics and laboratory capacity (Africa CDC, 2022).

Such networks can also reduce inequalities between countries by enabling access to expertise and infrastructure. Instead of concentrating advanced AI capabilities in a few major laboratories, regional ecosystems can distribute scientific capacity across the continent.

African collaboration should therefore move from project-based partnerships toward long-term scientific ecosystems capable of sustaining innovation.

7.6. Responsible and Ethical AI Governance

The sixth pillar recognizes that technological advancement must be accompanied by ethical and institutional governance. AI applications in microbiology involve sensitive issues related to genomic data, public health surveillance, privacy, accountability, and equity.

Responsible AI governance requires transparency in algorithmic decision-making, mechanisms for evaluating bias, protection of biological information, and clear institutional responsibilities. African countries must develop governance frameworks that encourage innovation while protecting scientific integrity and public trust (Moleka, 2026a-d).

Importantly, responsible AI governance should not simply import external ethical models. It should incorporate African perspectives on collective responsibility, knowledge sharing, and the social purpose of science.

AI governance must therefore ensure that technological transformation contributes to human well-being, health equity, and sustainable scientific development.

Table 2. African AI Laboratory Capacity Framework.

Pillar	Core Objective	Strategic Question	Expected Transformation
Smart laboratory infrastructure	Build digitally connected and resilient laboratories	Do laboratories possess the physical and technological foundations for AI?	From basic laboratories to intelligent scientific platforms
AI and digital readiness	Develop institutional capacity for AI adoption	Are laboratories prepared to integrate AI into workflows?	From data collection to data-driven intelligence
Scientific workforce development	Create interdisciplinary expertise	Do researchers possess AI and microbiology competencies?	From technology users to innovation producers
Data governance and interoperability	Build trustworthy data ecosystems	Can African institutions generate and govern their own data?	From data dependency to scientific sovereignty
Regional collaboration networks	Strengthen continental scientific ecosystems	Can countries share knowledge and infrastructure?	From isolated institutions to collective intelligence
Responsible AI governance	Ensure ethical and equitable deployment	Can AI innovation remain aligned with public values?	From technological adoption to responsible transformation

Table 2. African AI Laboratory Capacity Framework.

Pillar	Core Objective	Strategic Question	Expected Transformation
Smart laboratory infrastructure	Build digitally connected and resilient laboratories	Do laboratories possess the physical and technological foundations for AI?	From basic laboratories to intelligent scientific platforms
AI and digital readiness	Develop institutional capacity for AI adoption	Are laboratories prepared to integrate AI into workflows?	From data collection to data-driven intelligence
Scientific workforce development	Create interdisciplinary expertise	Do researchers possess AI and microbiology competencies?	From technology users to innovation producers
Data governance and interoperability	Build trustworthy data ecosystems	Can African institutions generate and govern their own data?	From data dependency to scientific sovereignty
Regional collaboration networks	Strengthen continental scientific ecosystems	Can countries share knowledge and infrastructure?	From isolated institutions to collective intelligence
Responsible AI governance	Ensure ethical and equitable deployment	Can AI innovation remain aligned with public values?	From technological adoption to responsible transformation

The framework demonstrates that AI readiness is multidimensional. A laboratory may possess advanced sequencing equipment but remain unable to benefit from AI without trained personnel, reliable data systems, and governance mechanisms. Sustainable transformation emerges only when all six pillars develop together.

8. Discussion

8.1. AI as a Scientific Capacity Accelerator

The findings of this study suggest that AI should be conceptualized as a scientific capacity accelerator rather than merely a technological innovation. Traditional approaches often present AI as an efficiency-enhancing tool capable of automating existing laboratory processes. However, the African context reveals a broader possibility: AI can contribute to the transformation of scientific institutions themselves.

When integrated into appropriate ecosystems, AI can accelerate several dimensions of microbiological capacity. It can improve diagnostic speed, enhance genomic surveillance, strengthen antimicrobial resistance monitoring, and expand research productivity. More importantly, AI can enable African institutions to participate more actively in global scientific knowledge production.

The transformative potential of AI therefore lies not only in automation but in expanding the cognitive capacity of scientific systems. Laboratories equipped with AI capabilities can analyze larger datasets, identify complex biological patterns, and generate new forms of scientific insight.

However, AI cannot replace foundational scientific capacity. Countries with weak laboratory systems, limited research financing, and insufficient workforce development may struggle to benefit from AI. The relationship between AI and scientific capacity is therefore mutually reinforcing: strong institutions enable AI adoption, while AI can accelerate institutional development.

8.2. Lessons from African Laboratory Experiences

The empirical cases analyzed in this study reveal that African countries are not starting from zero. Across the continent, multiple institutions have developed significant expertise in microbiology, genomics, and outbreak response.

South Africa’s KRISP demonstrates how sustained investment in sequencing infrastructure, scientific leadership, and international collaboration can create globally competitive genomic capabilities. Senegal illustrates the importance of regional scientific hubs capable of supporting diagnostics and innovation beyond national borders.

Kenya and Nigeria demonstrate the importance of connecting laboratory systems with national surveillance mechanisms. Uganda highlights how repeated outbreak experiences can generate institutional learning and preparedness. The Democratic Republic of Congo illustrates scientific resilience developed through continuous engagement with epidemic challenges. The Central African Republic demonstrates that innovation can emerge even under severe resource limitations.

These cases suggest that AI strategies should not follow a uniform model. Instead, they should build upon existing scientific strengths, institutional histories, and local innovation ecosystems.

8.3. Moving from Technology Dependency Toward Scientific Sovereignty

One of the most significant implications of AI adoption in African microbiology concerns scientific sovereignty. Historically, many African countries have participated in global health research primarily as sources of biological samples, epidemiological information, and clinical data. Advanced analysis, however, has often been conducted outside the continent.

AI provides an opportunity to transform this relationship. By developing local computational capacity, African institutions can increasingly analyze their own biological data, generate original scientific knowledge, and participate more equally in international research collaborations.

Scientific sovereignty does not mean isolation from global networks. Rather, it implies the ability to engage globally from a position of greater capability, ownership, and intellectual contribution.

The development of AI-enabled microbiology laboratories can therefore become part of a broader strategy for strengthening Africa’s knowledge economy and innovation capacity.

8.4. Implications for Global Health Security

The development of AI-enabled microbiology capacity in Africa has direct implications for global health security. Infectious disease threats are increasingly shaped by globalization, climate change, ecological disruption, and population mobility. Effective prevention requires distributed scientific capacity capable of detecting and responding to emerging pathogens rapidly.

Strengthening African laboratories through AI can improve global surveillance networks by expanding pathogen detection capabilities in regions where emerging diseases frequently appear. Rather than viewing African scientific development as a regional issue, international actors should recognize it as a critical component of collective health security.

The future of global preparedness depends on a more balanced scientific ecosystem in which all regions possess the capacity to contribute to pathogen surveillance, innovation, and response.

8.5. Theoretical Contribution

This study contributes to the emerging literature on AI governance, digital health transformation, and scientific capacity building by proposing that AI adoption in microbiology should be understood as an ecosystem transformation process.

The African AI Laboratory Capacity Framework advances a perspective in which technology, institutions, knowledge, and ethics are inseparable. It moves beyond technology transfer models toward a model of capacity co-creation, where African laboratories become active producers of AI-enabled scientific innovation.

This perspective has implications not only for microbiology but also for broader debates concerning AI, development, and global knowledge systems.

9. Policy and Research Implications

The transformation of African microbiology laboratories through artificial intelligence requires coordinated action among governments, academic institutions, research organizations, continental bodies, international agencies, and development partners. The evidence examined in this study demonstrates that AI adoption cannot succeed through isolated technological investments. It requires a long-term strategy combining infrastructure development, scientific capacity building, ethical governance, and regional cooperation.

The policy implications of AI-enabled microbiology extend beyond laboratory modernization. They concern Africa’s broader scientific development, health sovereignty, innovation capacity, and contribution to global health security.

9.1. Implications for African Governments

African governments should position AI-enabled microbiology as a strategic component of national health security and scientific development policies. Investment in laboratory systems should move beyond emergency response approaches toward long-term capacity-building strategies integrating artificial intelligence, genomics, digital health, and data science.

Governments should prioritize the development of national AI and biotechnology strategies that include microbiology applications, genomic surveillance, antimicrobial resistance monitoring, and research innovation. Such strategies should be accompanied by sustainable financing mechanisms to ensure that AI initiatives continue beyond short-term international projects.

A major priority should be strengthening digital and physical infrastructure. Reliable electricity, internet connectivity, laboratory information systems, sequencing facilities, and computational resources represent essential foundations for AI adoption. Public investment in these areas will determine whether African countries become producers of scientific knowledge or remain dependent on external technological providers.

Governments should also promote interdisciplinary education by supporting programs that combine microbiology, artificial intelligence, bioinformatics, and public health. The creation of national centers of excellence in computational biology and AI-enabled health research could accelerate scientific transformation.

Finally, African governments should develop regulatory frameworks that encourage innovation while ensuring responsible management of biological data, privacy protection, and equitable access to AI benefits.

9.2. Implications for Universities

Universities represent the foundation for developing the human capital required for AI-enabled microbiology. Current academic structures often separate biological sciences, computer science, engineering, and public health disciplines. However, AI transformation requires professionals capable of working across these boundaries.

Universities should therefore redesign curricula to integrate artificial intelligence, machine learning, genomics, data science, and ethical governance into microbiology and biomedical training programs. New interdisciplinary degrees and research programs should prepare a generation of scientists capable of developing and applying AI solutions for African health challenges.

Universities should also strengthen research partnerships with hospitals, government laboratories, technology companies, and international institutions. Such collaborations can facilitate access to datasets, research infrastructure, and innovation opportunities.

Furthermore, African universities should promote open science approaches, regional research networks, and South–South collaboration to reduce fragmentation and strengthen collective scientific capacity.

9.3. Implications for Research Institutes

African research institutes occupy a critical position between academic knowledge production and practical public health applications. Institutions such as national biomedical research centers and public health laboratories should become innovation platforms where microbiology, AI, genomics, and epidemiology converge.

Research institutes should invest in developing locally relevant AI models trained on African biological and epidemiological datasets. This is essential because models developed using non-African data may fail to capture regional pathogen diversity, disease patterns, and laboratory realities.

Research organizations should also establish long-term programs focusing on AI applications in pathogen surveillance, antimicrobial resistance prediction, outbreak forecasting, and vaccine research. These efforts should include mechanisms for data sharing, reproducibility, and collaboration with global scientific networks.

A key priority should be strengthening institutional research autonomy. African researchers should participate not only in data collection but also in algorithm development, interpretation, publication, and technological innovation.

9.4. Implications for Africa CDC

Africa CDC has a central role in coordinating continental efforts toward AI-enabled microbiology transformation. Existing initiatives, particularly those focused on pathogen genomics and laboratory strengthening, provide an important foundation for integrating artificial intelligence into African health systems.

Africa CDC could develop a continental framework for AI in laboratory medicine, establishing common standards for data governance, interoperability, ethical AI use, and workforce development. Such a framework would help align national strategies and facilitate regional cooperation.

Africa CDC should also support the creation of continental AI-enabled surveillance platforms capable of integrating genomic, epidemiological, environmental, and clinical information. These systems could strengthen early warning mechanisms and improve preparedness for future outbreaks.

Additionally, Africa CDC could facilitate training networks, regional AI laboratories, and communities of practice connecting microbiologists, data scientists, policymakers, and public health professionals across the continent.

9.5. Implications for the World Health Organization

The World Health Organization has an important role in ensuring that AI transformation contributes to equitable global health outcomes. WHO should support the development of international standards that enable responsible AI adoption while recognizing the specific challenges faced by low- and middle-income countries.

WHO can contribute by promoting capacity-building initiatives, supporting ethical AI governance frameworks, and facilitating knowledge exchange between regions. Global health strategies should recognize that strengthening African laboratory capacity is not only a regional priority but a critical component of global pandemic preparedness.

WHO should also encourage more inclusive representation of African datasets, researchers, and institutions in global AI health initiatives. Without such inclusion, AI systems risk reproducing existing inequalities in global scientific knowledge production.

9.6. Implications for International Partners

International partners, including research organizations, development agencies, philanthropic foundations, and technology companies, should move from short-term technology transfer models toward sustainable capacity-building partnerships.

Future collaborations should emphasize co-development rather than simple deployment of external technologies. African institutions should participate in defining research priorities, developing AI solutions, managing data, and producing scientific outputs.

International support should focus on strengthening local ecosystems through investments in infrastructure, training, research funding, and institutional partnerships. Sustainable collaboration requires recognition of African researchers as equal partners in global scientific innovation.

The ultimate objective should be the emergence of interconnected scientific ecosystems where African laboratories contribute actively to global microbiological knowledge and health security.

Table 3 highlights that AI transformation requires a multi-level governance approach. No single institution can independently achieve sustainable AI-enabled microbiology capacity. Success depends on alignment between national policies, academic systems, research institutions, continental organizations, and international partners.

10. Conclusion

Artificial intelligence represents a major opportunity to transform microbiology laboratories across Africa by improving diagnosis, strengthening genomic surveillance, enhancing antimicrobial resistance monitoring, and accelerating biomedical innovation. The increasing availability of genomic technologies, digital platforms, and machine learning approaches creates new possibilities for African institutions to expand their scientific contributions and improve health security.

However, technology alone is insufficient. AI cannot generate sustainable transformation without strong laboratory systems, skilled scientific communities, reliable data ecosystems, ethical governance mechanisms, and long-term institutional commitment. The experience of African laboratories demonstrates that technological progress depends on the interaction between innovation and capacity development.

This study has proposed the African AI Laboratory Capacity Framework, which identifies six essential pillars for sustainable AI adoption: smart laboratory infrastructure, AI and digital readiness, scientific workforce development, data governance and interoperability, regional collaboration networks, and responsible AI governance. Together, these pillars provide a pathway for moving from fragmented technological adoption toward integrated scientific transformation.

The future of AI-enabled microbiology in Africa should therefore not be understood merely as the introduction of advanced tools into existing laboratories. It represents a broader opportunity to strengthen scientific sovereignty, promote knowledge production, and contribute more effectively to global health security.

By investing in institutions, skills, governance, and collaboration, African countries can transform AI from a technology imported from outside into a locally embedded capability that supports innovation, resilience, and sustainable development.